5.38 Interest of Early Determination of Bone Marrow Minimal Residual Disease by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: the Experience of the CLL2007FMP, an Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine, Cyclophosphamide, and Rituximab versus Fludarabine, Cyclophosphamide, and MabCampath in Previously Untreated B-Chronic Lymphocytic Leukemia Patients
2011 ◽
Vol 11
◽
pp. S269
◽
2013 ◽
Vol 84B
(2)
◽
pp. 96-103
◽
2008 ◽
Vol 81
(2)
◽
pp. 100-106
◽
2013 ◽
Vol 36
(2)
◽
pp. 165-171
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6523-6523
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6523-6523